Ambroxol Hydrochloride Granules

This product is a mucolytic agent that can increase the secretion of serous glands in the respiratory mucosa and reduce the secretion of mucous glands, thereby reducing sputum viscosity; it can also promote the secretion of pulmonary surfactant, increase bronchial ciliary movement, and make sputum easier to cough up.

Ambroxol Hydrochloride

It is suitable for the expectorant treatment of acute and chronic respiratory diseases accompanied by abnormal sputum secretion and poor sputum removal function, such as acute exacerbation of chronic bronchitis, asthmatic bronchitis, bronchiectasis and bronchial asthma.

Adults and children over 12 years old: Usually in the first 2-3 days of treatment, take 30 mg orally 3 times a day (equivalent to 90 mg of ambroxol hydrochloride per day), then take 30 mg orally 2 times a day (equivalent to 60 mg of ambroxol hydrochloride per day). Take after meals

In a few cases, the following adverse reactions may occur: gastrointestinal discomfort (such as nausea and stomach pain), allergic reactions of the skin and mucous membranes (such as swelling, rash, erythema, itching), dyspnea, facial swelling, fever with chills. Rarely, patients feel dryness of the mouth and airways, increased saliva secretion, increased nasal secretions, constipation and difficulty urinating after taking this product. In some occasional cases, strong hypersensitivity reactions have occurred, accompanied by severe circulatory disorders (anaphylactic shock). In this case, emergency medical assistance is necessary. There has been a report of allergic skin inflammation (contact dermatitis). If adverse reactions not mentioned above are found during medication or the user does not understand the effects of the drug, please consult your doctor or pharmacist. Once an allergic reaction occurs, this product should not be taken again.

This product is contraindicated for those who are allergic to the active ingredient ambroxol hydrochloride or any other components.

If used in combination with antitussives (cough suppressants), there is a risk of blockage of secretions due to a weakened cough reflex, so the therapeutic range of the drug must be carefully considered before combined use. If used in combination with antibiotics (amoxicillin, cefuroxime, erythromycin or doxycycline), the penetration of antibiotics into the lung tissue may be increased.

Keep tightly closed in a cool, dry place.

15mg

Tipr Pharmaceutical Co., Ltd.

• Founded in:

  1994-08-18

• Address:

  No. 29, Huixin Road, Binhai Science and Technology Park, Binhai Hi-tech Zone, Tianjin

• Tax NO.:

  91120116238991799D

• Registered Funds:

  50 million yuan

• Website:

  Log in to view

• Email:

  Log in to view